Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Pablo Villoslada Diaz, MD, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentNeurology
    Address675 Nelson Rising Lane
    San Francisco CA 94158
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University Santiago de CompostelaMedicineMedicine1990
      University Autonomous of BarcelonaPhDNeurosciences1996
      Hospital Vall d'Hebron, BarcelonaSpecialist NeurologyNeurology1995
      UCSFPostdocNeurology1998
      UNEDMaster in statisticsStatistics2001
      Collapse Awards and Honors
      AEGACA2014Award for the Galicia-Catalonia Entrepreneur Association to Medical and Science Achivements
      Spanish Neurological Society2012Award of the Spanish Neurological Society for research in the field of demyelinating diseases
      Spanish Neurological Society2007Award for the best research study in demyelinating diseases
      Spanish Neurological Society2004Spanish Multiple Sclerosis Foundation award
      Spanish Neurological Society2000Spanish Multiple Sclerosis Foundation award

      Collapse Overview 
      Collapse Overview
      Pablo Villoslada received his MD at the University of Santiago de Compostela (Spain) in 1990. He completed his speciality in Neurology in 1995 at the Hospital Vall d’Hebron (Spain) and his PhD in Neuroimmunology in 1996 at the Autonomous University of Barcelona (Spain). He moved to the University of California, San Fracisco (USA) as a postdoctoral fellow returning to Barcelona in 1998 and he worked as Assistant and Asociate Professor of the University of Navarra from 2001 to 2008.

      He is currently Adjunct Professor at the University of California, San Francisco and Group leader of the Neuroimmunology group of the Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Spain. Also he is founder and scientific advisor in Bionure Inc, Menlo Park, dedicated to the development of neuroprotective therapies for brain diseases.

      Pablo Villoslada has been active in neurosciences and translational research for more than 15 years contributing to the application of systems biology to neurological diseases, development of new therapies or biomarkers for Multiple Sclerosis, and clinical research assessment of the retinal nerve fiber layer with optic coherence tomography and cognition in brain diseases. He has published more than 120 papers in top journals in the field of neurology (Ann Neurol, Neurology, Arch Neurol, Brain, etc) and 9 patents in biomarkers and new therapies for brain diseases.

      Collapse Interests
      Neurology, Neurosciences, Neuroimmunology, Multiple Sclerosis, Neuromyelitis Optica, systems biology, precision medicine, biomarkers, imaging, therapies

      Collapse ORNG Applications 
      Collapse Featured Publications

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Aguilera-Albesa S, Crespo-Eguílaz N, Del Pozo JL, Villoslada P, Sánchez-Carpintero R. Anti-Basal Ganglia Antibodies and Streptococcal Infection in ADHD. J Atten Disord. 2015 Apr 16. PMID: 25882837.
        View in: PubMed
      2. Weinshenker BG, Barron G, Behne JM, Bennett JL, Chin PS, Cree BA, de Seze J, Flor A, Fujihara K, Greenberg B, Higashi S, Holt W, Khan O, Knappertz V, Levy M, Melia AT, Palace J, Smith TJ, Sormani MP, Van Herle K, VanMeter S, Villoslada P, Walton MK, Wasiewski W, Wingerchuk DM, Yeaman MR. Challenges and opportunities in designing clinical trials for neuromyelitis optica. Neurology. 2015 Apr 28; 84(17):1805-15. PMID: 25841026; PMCID: PMC4424131.
      3. Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015 Mar 17; 84(11):1165-73. PMID: 25695963; PMCID: PMC4371410.
      4. Gabilondo I, Martínez-Lapiscina EH, Fraga-Pumar E, Ortiz-Perez S, Torres-Torres R, Andorra M, Llufriu S, Zubizarreta I, Saiz A, Sanchez-Dalmau B, Villoslada P. Dynamics of retinal injury after acute optic neuritis. Ann Neurol. 2015 Mar; 77(3):517-28. PMID: 25559267.
        View in: PubMed
      5. Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J, Bestwick JP, Meier UC, Marta M, Costa GD, Runia T, Evdoshenko E, Lazareva N, Thouvenot E, Iaffaldano P, Direnzo V, Khademi M, Piehl F, Comabella M, Sombekke M, Killestein J, Hegen H, Rauch S, D'Alfonso S, Alvarez-Cermeño JC, Kleinová P, Horáková D, Roesler R, Lauda F, Llufriu S, Avsar T, Uygunoglu U, Altintas A, Saip S, Menge T, Rajda C, Bergamaschi R, Moll N, Khalil M, Marignier R, Dujmovic I, Larsson H, Malmestrom C, Scarpini E, Fenoglio C, Wergeland S, Laroni A, Annibali V, Romano S, Martínez AD, Carra A, Salvetti M, Uccelli A, Torkildsen Ø, Myhr KM, Galimberti D, Rejdak K, Lycke J, Frederiksen JL, Drulovic J, Confavreux C, Brassat D, Enzinger C, Fuchs S, Bosca I, Pelletier J, Picard C, Colombo E, Franciotta D, Derfuss T, Lindberg R, Yaldizli Ö, Vécsei L, Kieseier BC, Hartung HP, Villoslada P, Siva A, Saiz A, Tumani H, Havrdová E, Villar LM, Leone M, Barizzone N, Deisenhammer F, Teunissen C, Montalban X, Tintoré M, Olsson T, Trojano M, Lehmann S, Castelnovo G, Lapin S, Hintzen R, Kappos L, Furlan R, Martinelli V, Comi G, Ramagopalan SV, Giovannoni G. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler. 2015 Jul; 21(8):1013-24. PMID: 25680984.
        View in: PubMed
      6. Malhotra A, Gündel M, Rajput AM, Mevissen HT, Saiz A, Pastor X, Lozano-Rubi R, Martinez-Lapsicina EH, Zubizarreta I, Mueller B, Kotelnikova E, Toldo L, Hofmann-Apitius M, Villoslada P. Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology. PLoS One. 2015; 10(2):e0116718. PMID: 25665127; PMCID: PMC4321837.
      7. Bennett JL, de Seze J, Lana-Peixoto M, Palace J, Waldman A, Schippling S, Tenembaum S, Banwell B, Greenberg B, Levy M, Fujihara K, Chan KH, Kim HJ, Asgari N, Sato DK, Saiz A, Wuerfel J, Zimmermann H, Green A, Villoslada P, Paul F. Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler. 2015 May; 21(6):678-88. PMID: 25662342; PMCID: PMC4425816.
      8. Martínez-Lapiscina EH, Fraga-Pumar E, Gabilondo I, Martínez-Heras E, Torres-Torres R, Ortiz-Pérez S, Llufriu S, Tercero A, Andorra M, Roca MF, Lampert E, Zubizarreta I, Saiz A, Sanchez-Dalmau B, Villoslada P. The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS. BMC Res Notes. 2014; 7:910. PMID: 25512202; PMCID: PMC4300678.
      9. Llufriu S, Sepúlveda M, Blanco Y, Marín P, Moreno B, Berenguer J, Gabilondo I, Martínez-Heras E, Sola-Valls N, Arnaiz JA, Andreu EJ, Fernández B, Bullich S, Sánchez-Dalmau B, Graus F, Villoslada P, Saiz A. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One. 2014; 9(12):e113936. PMID: 25436769; PMCID: PMC4250058.
      10. Sepúlveda M, Llufriu S, Blanco Y, Solà-Valls N, La Puma D, Berenguer J, Villoslada P, Saiz A. Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report. J Neurol. 2015 Jan; 262(1):219-21. PMID: 25408366.
        View in: PubMed
      11. Iranzo J, Villoslada P. Autoimmunity and tumor immunology: two facets of a probabilistic immune system. BMC Syst Biol. 2014; 8:120. PMID: 25385554; PMCID: PMC4236429.
      12. Gustafsson M, Nestor CE, Zhang H, Barabási AL, Baranzini S, Brunak S, Chung KF, Federoff HJ, Gavin AC, Meehan RR, Picotti P, Pujana MÀ, Rajewsky N, Smith KG, Sterk PJ, Villoslada P, Benson M. Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Med. 2014; 6(10):82. PMID: 25473422; PMCID: PMC4254417.
      13. Kotelnikova E, Bernardo-Faura M, Silberberg G, Kiani NA, Messinis D, Melas IN, Artigas L, Schwartz E, Mazo I, Masso M, Alexopoulos LG, Mas JM, Olsson T, Tegner J, Martin R, Zamora A, Paul F, Saez-Rodriguez J, Villoslada P. Signaling networks in MS: a systems-based approach to developing new pharmacological therapies. Mult Scler. 2015 Feb; 21(2):138-46. PMID: 25112814.
        View in: PubMed
      14. Martínez-Lapiscina EH, Sanchez-Dalmau B, Fraga-Pumar E, Ortiz-Perez S, Tercero-Uribe AI, Torres-Torres R, Villoslada P. The visual pathway as a model to understand brain damage in multiple sclerosis. Mult Scler. 2014 Nov; 20(13):1678-85. PMID: 25013155.
        View in: PubMed
      15. Petzold A, Wattjes MP, Costello F, Flores-Rivera J, Fraser CL, Fujihara K, Leavitt J, Marignier R, Paul F, Schippling S, Sindic C, Villoslada P, Weinshenker B, Plant GT. The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol. 2014 Aug; 10(8):447-58. PMID: 25002105.
        View in: PubMed
      16. Villoslada P. Closing the clinical-radiological paradox using the visual pathway in multiple sclerosis. Invest Ophthalmol Vis Sci. 2014 Jun; 55(6):3765. PMID: 24939034.
        View in: PubMed
      17. Schippling S, Balk Lj, Costello F, Albrecht P, Balcer L, Calabresi P, Frederiksen J, Frohman E, Green A, Klistorner A, Outteryck O, Paul F, Plant G, Traber G, Vermersch P, Villoslada P, Wolf S, Petzold A. Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler. 2015 Feb; 21(2):163-70. PMID: 24948688.
        View in: PubMed
      18. Jiménez J, López AM, Cruz J, Esteban FJ, Navas J, Villoslada P, Ruiz de Miras J. A Web platform for the interactive visualization and analysis of the 3D fractal dimension of MRI data. J Biomed Inform. 2014 Oct; 51:176-90. PMID: 24909817.
        View in: PubMed
      19. Keller J, Sánchez-Dalmau BF, Villoslada P. Lesions in the posterior visual pathway promote trans-synaptic degeneration of retinal ganglion cells. PLoS One. 2014; 9(5):e97444. PMID: 24857938; PMCID: PMC4032251.
      20. Bermel RA, Villoslada P. Retrograde trans-synaptic degeneration in MS: a missing link? Neurology. 2014 Jun 17; 82(24):2152-3. PMID: 24838792.
        View in: PubMed
      21. Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Mar Albà M, Navarro A. Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project. Genome Biol Evol. 2014 Apr; 6(4):846-60. PMID: 24682154; PMCID: PMC4104767.
      22. Moreno B, Lopez I, Fernández-Díez B, Gottlieb M, Matute C, Sánchez-Gómez MV, Domercq M, Giralt A, Alberch J, Collon KW, Zhang H, Parent JM, Teixido M, Giralt E, Ceña V, Posadas I, Martínez-Pinilla E, Villoslada P, Franco R. Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine. PLoS One. 2014; 9(3):e90671. PMID: 24599318; PMCID: PMC3944389.
      23. Martínez-Lapiscina EH, Fraga-Pumar E, Pastor X, Gómez M, Conesa A, Lozano-Rubí R, Sánchez-Dalmau B, Alonso A, Villoslada P. Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012. J Neurol. 2014 Apr; 261(4):759-67. PMID: 24532201.
        View in: PubMed
      24. Martínez-Lapiscina EH, Ortiz-Pérez S, Fraga-Pumar E, Martínez-Heras E, Gabilondo I, Llufriu S, Bullich S, Figueras M, Saiz A, Sánchez-Dalmau B, Villoslada P. Colour vision impairment is associated with disease severity in multiple sclerosis. Mult Scler. 2014 Aug; 20(9):1207-16. PMID: 24399824.
        View in: PubMed
      25. Gabilondo I, Martínez-Lapiscina EH, Martínez-Heras E, Fraga-Pumar E, Llufriu S, Ortiz S, Bullich S, Sepulveda M, Falcon C, Berenguer J, Saiz A, Sanchez-Dalmau B, Villoslada P. Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol. 2014 Jan; 75(1):98-107. PMID: 24114885.
        View in: PubMed
      26. Di Penta A, Chiba A, Alloza I, Wyssenbach A, Yamamura T, Villoslada P, Miyake S, Vandenbroeck K. A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation. PLoS One. 2013; 8(12):e83119. PMID: 24349442; PMCID: PMC3859644.
      27. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. Association of multiple sclerosis susceptibility variants and early attack location in the CNS. PLoS One. 2013; 8(10):e75565. PMID: 24130718; PMCID: PMC3794979.
      28. Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E. Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. PLoS One. 2013; 8(10):e75416. PMID: 24130709; PMCID: PMC3793991.
      29. Marro M, Taubes A, Abernathy A, Balint S, Moreno B, Sanchez-Dalmau B, Martínez-Lapiscina EH, Amat-Roldan I, Petrov D, Villoslada P. Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis. J Biophotonics. 2014 Sep; 7(9):724-34. PMID: 24019106.
        View in: PubMed
      30. Velez de Mendizabal N, Hutmacher MM, Troconiz IF, Goñi J, Villoslada P, Bagnato F, Bies RR. Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach. PLoS One. 2013; 8(9):e73361. PMID: 24039924; PMCID: PMC3764125.
      31. Llufriu S, Martinez-Heras E, Fortea J, Blanco Y, Berenguer J, Gabilondo I, Ibarretxe-Bilbao N, Falcon C, Sepulveda M, Sola-Valls N, Bargallo N, Graus F, Villoslada P, Saiz A. Cognitive functions in multiple sclerosis: impact of gray matter integrity. Mult Scler. 2014 Apr; 20(4):424-32. PMID: 24005025.
        View in: PubMed
      32. Ortiz-Pérez S, Martínez-Lapiscina EH, Gabilondo I, Fraga-Pumar E, Martínez-Heras E, Saiz A, Sanchez-Dalmau B, Villoslada P. Retinal periphlebitis is associated with multiple sclerosis severity. Neurology. 2013 Sep 3; 81(10):877-81. PMID: 23902700; PMCID: PMC3885218.
      33. Pertsovskaya I, Abad E, Domedel-Puig N, Garcia-Ojalvo J, Villoslada P. Transient oscillatory dynamics of interferon beta signaling in macrophages. BMC Syst Biol. 2013; 7:59. PMID: 23837526; PMCID: PMC3711797.
      34. Gabilondo I, Sepúlveda M, Ortiz-Perez S, Fraga-Pumar E, Martínez-Lapiscina EH, Llufriu S, Solá N, Saiz A, Sanchez-Dalmau B, Villoslada P. Retrograde retinal damage after acute optic tract lesion in MS. J Neurol Neurosurg Psychiatry. 2013 Jul; 84(7):824-6. PMID: 23715916.
        View in: PubMed
      35. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Vander-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP. Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]. Mult Scler. 2013 May; 19(6):831-2. PMID: 23658240.
        View in: PubMed
      36. Martinez-Pasamar S, Abad E, Moreno B, Velez de Mendizabal N, Martinez-Forero I, Garcia-Ojalvo J, Villoslada P. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity. BMC Syst Biol. 2013; 7:34. PMID: 23618467; PMCID: PMC3651362.
      37. di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, Escala N, Vandenbroeck K, Comella JX, Villoslada P. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One. 2013; 8(2):e54722. PMID: 23431360; PMCID: PMC3576396.
      38. Rodrigues P, Prats-Galino A, Gallardo-Pujol D, Villoslada P, Falcon C, Prckovska V. Evaluating structural connectomics in relation to different Q-space sampling techniques. Med Image Comput Comput Assist Interv. 2013; 16(Pt 1):671-8. PMID: 24505725.
        View in: PubMed
      39. García-Redondo A, Dols-Icardo O, Rojas-García R, Esteban-Pérez J, Cordero-Vázquez P, Muñoz-Blanco JL, Catalina I, González-Muñoz M, Varona L, Sarasola E, Povedano M, Sevilla T, Guerrero A, Pardo J, López de Munain A, Márquez-Infante C, de Rivera FJ, Pastor P, Jericó I, de Arcaya AÁ, Mora JS, Clarimón J, Gonzalo-Martínez JF, Juárez-Rufián A, Atencia G, Jiménez-Bautista R, Morán Y, Mascías J, Hernández-Barral M, Kapetanovic S, García-Barcina M, Alcalá C, Vela A, Ramírez-Ramos C, Galán L, Pérez-Tur J, Quintáns B, Sobrido MJ, Fernández-Torrón R, Poza JJ, Gorostidi A, Paradas C, Villoslada P, Larrodé P, Capablo JL, Pascual-Calvet J, Goñi M, Morgado Y, Guitart M, Moreno-Laguna S, Rueda A, Martín-Estefanía C, Cemillán C, Blesa R, Lleó A. Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat. 2013 Jan; 34(1):79-82. PMID: 22936364.
        View in: PubMed
      40. Sepúlveda M, Blanco Y, Rovira A, Rio J, Mendibe M, Llufriu S, Gabilondo I, Villoslada P, Castilló J, Corral J, Ayuso T, Iñiguez C, Santos S, Guijarro C, Ramió-Torrentà L, Sempere AP, Olascoaga J, Graus F, Montalban X, Saiz A. Analysis of prognostic factors associated with longitudinally extensive transverse myelitis. Mult Scler. 2013 May; 19(6):742-8. PMID: 23037550.
        View in: PubMed
      41. Fernández V, Valls-Sole J, Relova JL, Raguer N, Miralles F, Dinca L, Taramundi S, Costa-Frossard L, Ferrandiz M, Ramió-Torrentà L, Villoslada P, Saiz A, Calles C, Antigüedad A, Alvarez-Cermeño JC, Prieto JM, Izquierdo G, Montalbán X, Fernández O. [Recommendations for the clinical use of motor evoked potentials in multiple sclerosis]. Neurologia. 2013 Sep; 28(7):408-16. PMID: 22995526.
        View in: PubMed
      42. Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, Falcon C, Berenguer J, Bargallo N, Villoslada P, Graus F, Valls-Sole J, Saiz A. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study. PLoS One. 2012; 7(5):e37167. PMID: 22606347; PMCID: PMC3351399.
      43. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek BO, Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung HP. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. 2012 Dec; 18(12):1721-36. PMID: 22457345; PMCID: PMC3573672.
      44. Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A. Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler. 2012 Jul; 18(7):991-9. PMID: 22291035.
        View in: PubMed
      45. Villoslada P, Baranzini S. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis. J Neuroimmunol. 2012 Jul 15; 248(1-2):58-65. PMID: 22281286.
        View in: PubMed
      46. Moreno B, Espejo C, Mestre L, Suardiaz M, Clemente D, de Castro F, Fernández-Fernández Ó, Montalban X, Villoslada P, Guaza C. [Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]. Rev Neurol. 2012 Jan 16; 54(2):114-24. PMID: 22234570.
        View in: PubMed
      47. Boronat A, Sepúlveda M, Llufriu S, Sabater L, Blanco Y, Gabilondo I, Solà N, Villoslada P, Dalmau J, Graus F, Saiz A. Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis. J Neuroimmunol. 2012 Mar; 244(1-2):103-6. PMID: 22245283.
        View in: PubMed
      48. Moreno B, Jukes JP, Vergara-Irigaray N, Errea O, Villoslada P, Perry VH, Newman TA. Systemic inflammation induces axon injury during brain inflammation. Ann Neurol. 2011 Dec; 70(6):932-42. PMID: 22190366.
        View in: PubMed
      49. Oyanguren-Desez O, Rodríguez-Antigüedad A, Villoslada P, Domercq M, Alberdi E, Matute C. Gain-of-function of P2X7 receptor gene variants in multiple sclerosis. Cell Calcium. 2011 Nov; 50(5):468-72. PMID: 21906809.
        View in: PubMed
      50. D'Intino G, Lorenzini L, Fernandez M, Taglioni A, Perretta G, Del Vecchio G, Villoslada P, Giardino L, Calzà L. Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism. J Neuroendocrinol. 2011 Sep; 23(9):778-90. PMID: 21707794.
        View in: PubMed
      51. Gabilondo I, Saiz A, Galán L, González V, Jadraque R, Sabater L, Sans A, Sempere A, Vela A, Villalobos F, Viñals M, Villoslada P, Graus F. Analysis of relapses in anti-NMDAR encephalitis. Neurology. 2011 Sep 6; 77(10):996-9. PMID: 21865579.
        View in: PubMed
      52. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 Aug 11; 476(7359):214-9. PMID: 21833088; PMCID: PMC3182531.
      53. Blanco Y, Ercilla-González G, Llufriu S, Casanova-Estruch B, Magraner MJ, Ramió-Torrentá L, Mendibe-Bilbao MM, Uclés-Sánchez AJ, Casado-Chocán JL, López de Munain A, Ramo-Tello C, Santos-Lasaosa S, Fernández-Bolaños Porras R, Segura-Bruna N, Sepulveda-Gázquez M, Villoslada P, Graus F, Saiz A. [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica]. Rev Neurol. 2011 Aug 1; 53(3):146-52. PMID: 21748712.
        View in: PubMed
      54. Vélez de Mendizábal N, Carneiro J, Solé RV, Goñi J, Bragard J, Martinez-Forero I, Martinez-Pasamar S, Sepulcre J, Torrealdea J, Bagnato F, Garcia-Ojalvo J, Villoslada P. Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis. BMC Syst Biol. 2011; 5:114. PMID: 21762505; PMCID: PMC3155504.
      Pablo's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP